Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481754 · ClinicalTrials.gov registry record
Benign Reproductive Tissue Analysis for Endometrial Cancer Markers
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 359
- Enrollment target
NCT00481754: Completed study, sponsored by National Cancer Institute (NCI).
NCT00481754 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 359 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00481754 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 359 participants
- Enrollment target
Study Summary
Background: * Endometrial cancer (cancer of the lining of the uterus) is the most common gynecologic cancer in the United States. * Currently, there are no markers (components of blood and tissue that determine who might be at risk for developing cancer) for endometrial cancer. Objectives: -To see if women who are undergoing hysterectomy are willing to provide blood and tissue samples to help doctors identify markers that would indicate increased risk for developing endometrial cancer. Eligibility: -Women between 35 and 54 years of age who will undergo hysterectomy for a non-cancerous condition, such as uterine fibroids, uterine prolapse, abnormal uterine bleeding, and others at Magee-Women's Hospital in Pittsburgh, Penn. Design: * Patients' medical records are reviewed and patients complete a questionnaire including information on race and ethnic background, education, marital status, family history, height, weight, pregnancy history, smoking history, medication history, history about menstrual periods and menopausal symptoms. * Patients provide blood and urine samples before surgery. * A sample of fat tissue is removed during surgery in patients undergoing abdominal surgery. * Tissue samples from the removed uterus (and ovaries if the ovaries are also removed) are collected and analyzed for markers for endometrial cancer.
Primary Outcome
Successful enrollment of women undergoing benign surgery, surgery because of high risk of ovarian cancer, or surgery because of diagnosed ovarian cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 359 participants |
| Start Date | 2006-04-24 |
| Est. Completion | 2020-11-13 |
What the finished NCT00481754 record still lists
NCT00481754 is an observational study that tracks outcomes without assigning an intervention. The registered 359 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00481754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00481754 about?
NCT00481754 is a clinical study titled "Benign Reproductive Tissue Analysis for Endometrial Cancer Markers". Background: * Endometrial cancer (cancer of the lining of the uterus) is the most common gynecologic cancer in the United States. * Currently, there are no markers (components of blood and tissue that determine who might be at risk for developing cancer) for endometrial cancer. Objectives: -To se...
What is the current status of trial NCT00481754?
This trial is currently completed. The enrollment target is 359 participants. The study started on 2006-04-24. Estimated completion is 2020-11-13.
Who is sponsoring clinical trial NCT00481754?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05118789 · 359 participants · Phase 1
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI